ArticleCureus2026
Severe Myocardial Bridging Without Obstructive Coronary Artery Disease Presenting as Non-ST-Elevation Myocardial Infarction: A Management Challenge in Sinus Bradycardia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocardial bridging (MB) is an anomaly in which a segment of a coronary artery takes an intramyocardial route. It can increase the risk of cardiovascular complications. Beta-blockers (BB) are usually the first line of treatment, and management may be challenging in patients with bradycardia. A 53-year-old male former smoker with hypertension and dyslipidemia presented to the emergency department complaining of retrosternal chest pain that awakened him from sleep and dyspnea. Upon evaluation, an electrocardiogram (ECG) revealed sinus bradycardia with T-wave inversions in leads II, III, aVF, and V3-V6. High-sensitivity troponin peaked at 335 pg/mL (4-79 pg/mL), and the patient was admitted with a diagnosis of non-ST-elevation myocardial infarction (NSTEMI). He was given 324 mg of aspirin, a heparin drip was started, and pain improved after sublingual nitroglycerin. Transthoracic echocardiogram (TTE) demonstrated a preserved left ventricular function without wall motion abnormalities. Coronary angiography identified a MB in the mid-left anterior descending coronary artery (LAD) without atherosclerotic disease. Coronary CT angiography described a 20 mm long and 7 mm deep MB with 90%-99% dynamic obstruction during end-systole. After a Heart Team meeting, the decision was to attempt medical management with metoprolol as tolerated. The patient remained angina-free and asymptomatic. A stress test prior to discharge was negative for ischemia or recurrent pain. After one-year follow-up, he has remained asymptomatic, with repeated unremarkable stress tests after reduction of BB dose. Severe MB may be associated with significant cardiovascular complications, including NSTEMI. Treatment poses a challenge in patients with bradycardia. This case illustrates that cautious beta-blocker therapy may be a feasible option in selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.